Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
The audit has been concluded with no major observations
The acquisition of Pivya is an important step in Alembic’s ability to provide branded pharmaceutical product to the US Healthcare market
Subscribe To Our Newsletter & Stay Updated